In an interview with PharmExec Associate Editor Don Tracy, Jingsong Wang discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033.
Recent Licensing Agreement Poised to Advance Company ADC
You May Also Like
+ There are no comments
Add yours